US Patent 10799453 Amlodipine formulations
Patent 10799453 was granted and assigned to Silvergate Pharmaceuticals, Inc. on October, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10799453 Amlodipine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
